Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 550
Selected: 0
NCT IDTitle
NCT03664843Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients
NCT06404840Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study
NCT04389177Pembrolizumab Plus Paclitaxel, Cisplatin Followed by Surgery for Locally Advanced ESCC (KEYSTONE-001)
NCT01815853Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer
NCT07065175KANGFUPEN Liquid Dressing for Chronic Radiation-Induced Rectal Injury
NCT01744925Icotinib at Different Doses in Second-line Treatment for Non-small Cell Lung Cancer Patients With Wild Type EGFR
NCT05218226Avatrombopag for Chemotherapy-induced Thrombocytopenia
NCT07374068Prognostic Model of Elderly Hodgkin Lymphoma in China
NCT03478449The Criteria for Lymph Node Sorting for Pathological Examination in Gastric Cancer
NCT00973310Erlotinib Concurrent With Radiation Therapy in Non-small-cell Lung Cancer
NCT06084897Radiotherapy in Patients With Metastatic Esophageal Cancer Responding to PD-1 Inhibitor Plus Chemotherapy
NCT07452848Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy
NCT06954558A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor
NCT05871099Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
NCT06492447Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer
NCT07409298Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy
NCT01634984The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer
NCT06093438Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer
NCT05678933AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH
NCT02745509Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS)
NCT05025033Chemotherapy Combined With Apatinib and PD-1 Antibody
NCT04158193Acupuncture for Breast Cancer Related Lymphedema
NCT04273100PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC
NCT07277972Iparomlimab and Tuvonralimab Injection in Combination With Lenvatinib or Axitinib for the Treatment of Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma That Has Failed First-Line Systemic Therapy
NCT05864755HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma
NCT03308552Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02
NCT05908747Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer
NCT05871918A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer
NCT07078292The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
NCT07491822A Single-Arm, Single-Center, Phase II Clinical Study of Camrelizumab Combined With Radiochemotherapy as Neoadjuvant Therapy for Early-Stage Triple-Negative Breast Cancer
NCT03222440Combination of Radiotherapy and SHR-1210 to Treat Patients With ESCC
NCT03983096Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.
NCT06102746Clinical Study of Surufatinib Plus Sintilimab Combined With Chemotherapy in the Treatment of Advanced Gastric Neuroendocrine Carcinoma
NCT03708042A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT04908566Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
NCT04725942Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients
NCT01637350Digestive Tract Reconstruction After Gastrectomy of Gastric Cancer With Type 2 Diabetes
NCT06495541The Real World Study of Pyrotinib in the Treatment of Advanced Breast Cancer With HER2 Positive
NCT01242124Impact of the Techniques for Intrathoracic Esophagogastric Anastomosis on Outcome in Ivor-Lewis Oesophagectomy
NCT07410234Phase II Exploratory Study of Toripalimab Combined With SBRT in HER2-Negative Breast Cancer Patients With Insensitivity to Neoadjuvant Chemotherapy
NCT06033482The Possible Range of No.12a Lymph Node Dissection of Locally Advanced Gastric Cancer
NCT07078305Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
NCT06288360Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
NCT05596435Early Detection of Pancreatic Cancer
NCT05679050Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
NCT05076097A Study of OLR in First-line Treatment of Mantle Cell Lymphoma
NCT06395870Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
NCT05325190Granisetron Transdermal Patch System for Prevention of CINV by CapeOX
NCT06102759Adebrelimab and Fruquintinib Combined With Paclitaxel/Albumin Paclitaxel for Advanced Gastric Cancer After PD-1 Antibody Failed
NCT04969029Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations